Skip to main content
Clinical Trials/CTRI/2023/06/053638
CTRI/2023/06/053638Not yet recruitingPhase 2/3

clinical study to evaluate the effect of modified mukhadooshikari lepa in youvana pidaka

RGUHS1 site in 1 country10 target enrollmentStarted: July 6, 2023Last updated:
Conditions

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
Reducing the size of youvana pidaka, after the applicationof mukhadooshikari lepa

Study Overview

Brief Summary

youvana pidaka (acne vulgaris), is most common skin care problem seen in age group of 17 -30 years old. it is caused by kapha - vata- rakta dusti of individual.in ashtanga hrdaya, mukhadooshikari lepa application  is advised, as an external therapy. Considering the disadvantages of lepa, it is replaced with the gel form, because of its Four Major Benefits including Lightweight , Quickly absorbed , Non greasy , Hydrating for longer period.Mukhadooshikari lepa contains extract of vacha , manjishta, lodra, pushkaramoola, dhanyaka , usheera ,masura, vata along with carbopol 940, propylene glycol, ethanol, methylparaben, propylparaben. Here by an attempt is made to evaluate the effectiveness of mukhadooshikari lepa in youvana pidaka, 10 participants will be selected and advise for the external application of mukhadooshikari lepa -3gm -twice daily and the assessment will be recorded on the  0th day and  15th  day and will be analysed.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Open Label

Eligibility Criteria

Ages
17.00 Year(s) to 30.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Patients complaining of pidaka over the face with history of more than one year.
  • •2.Patients between the age group of 17 and 30 years.

Exclusion Criteria

  • •1.Patients having pidaka of other khusdra roga and kusta 2.Patients having pidaka on places other than face.

Outcomes

Primary Outcomes

Reducing the size of youvana pidaka, after the applicationof mukhadooshikari lepa

Time Frame: baseline, 1 week

Secondary Outcomes

  • Modification of lepa into Gel(0/15DAY)

Investigators

Sponsor
RGUHS
Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials